Navigation Links
'Exercise pill' switches on gene that tells cells to burn fat

the genetic metabolic engineering that created the marathon mouse is permanent, turned on before birth. While a dramatic proof of concept that metabolic engineering is a potentially viable approach, it offers no help to an adult whose muscles are already formed and who now would benefit greatly from having more active, fat-burning muscles.

That is why the potential of chemical metabolic engineering - possibly a one-a-day pill as opposed to permanent genetic metabolic engineering - is so exciting, says Dr. Evans. In today’s society, too few people get an ideal amount of exercise, some because of medical problems or excess weight that makes exercise difficult. Having access to an "exercise pill" would improve the quality of muscles, since muscles like to be exercised, and increase the burning of energy or excess fat in the body. And that would result in less fatty tissue, lower amounts of fat circulating in the blood, lower blood glucose levels and less resistance to insulin, lowering the risks of heart disease and diabetes.

The ability to chemically engineer changes in metabolism also has given the researchers more insight into how the PPAR-d switch works, says Dr. Evans. Genetically engineering changes in metabolism in the marathon mice triggers both increased fat burning and increased endurance. Adult normal mice that receive the drug to switch on PPAR-d show increased fat burning and resistance to weight gain, but they do not show increased endurance. Dr. Evans says this suggests the delta switch can operate in different modes, and the laboratory is in the process of figuring out exactly how. He hopes his strategy will make it possible.
'"/>

Source:Federation of American Societies for Experimental Biology


Page: 1 2

Related biology news :

1. Switching to new anti-bacterial targets: Riboswitches
2. Nano machine switches between biological and silicon worlds
3. Flick of a protein switches immune response
4. Light-sensitive photoswitches could restore sight to those with macular degeneration
5. Gene therapy research switches off joint inflammation; switches on genetic process of joint repair
6. Beyond the DNA: Chemical signatures reveal genetic switches in the genome
7. Leprosy genome tells story of human migrations, French researchers report in Science
8. Immune systems distress signal tells bacteria when to strike back
9. DNA from feathers tells tale of eagle fidelity
10. Researchers find gland that tells fruit flies when to stop growing
11. Microbiology text tells stories, offers online resources
Post Your Comments:
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Consumer Reports Health News August 2009 55382 1Consumer Reports Health News August 2009 55382 2Consumer Reports Health News August 2009 55382 3Consumer Reports Health News August 2009 55382 4Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 1Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 1Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 3Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 4
...entists have identified one of the genes implicate...mmon cause of blindness in developed countries. , ...et , adds to the growing understanding of the gene...ich the researchers believe should ultimately lead...o-thirds of people aged 80 years or older are affe...
...versity of Iowa researchers and colleagues in Fran...tentially fatal human heart rhythm disorder called...drome," the disease affects approximately one in 6... for 50 percent or more of the permanent pacemaker...wly discovered gene variant is rare, the study pro...
... atomic-resolution view of an enzyme found only in...f Washington (UW) clues about how this enzyme, ess...odiesterase 6 (PDE6), is central to the way light ... signals to the brain. , This particular form of...the retina and has not been well-researched, in co...
Other Biology News:Genetic finding implicates innate immune system in major cause of blindness 2Study provides insight on a common heart rhythm disorder 2Study provides insight on a common heart rhythm disorder 3Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye 2
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...N.J. and EMERYVILLE, Calif., May 14 Bayer HealthC..., Inc. (Nasdaq: ONXX ) today announced that more...(sorafenib) tablets will be presented at the 2009 ...l meeting. , , "Nexavar has a proven track record... hepatocellular carcinoma (HCC), or liver cancer, ...
..., May 14 ANY LAB TEST NOW(R), the first retail di...ations nationwide, has partnered with Atherotech, ...to provide the VAP(R) Cholesterol Test direct to c...ol Test is an expanded cholesterol profile that id... the first cholesterol test to directly measure LD...
...LE, Md., May 14 Vanda Pharmaceuticals Inc. (Nasda...osters on its newly approved atypical antipsychoti... Psychiatric Association (APA) annual meeting in S... for the acute treatment of schizophrenia in adult...teon at APA. Tasimelteon is an investigational co...
Other Biology Technology:Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 2VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 2Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 4
SURE E. coli Strain from Stratagene
21-mer duplex from B-Bridge International
...dy to CRF The antibody blocks specificially with ... Cells and fibres are found in the paraventricular...reated 4% FA perfused tissue. Immunogen: CRF: ...s-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-...
JM101 E. coli Strain from Stratagene
Biology Products: